Researchers seek new pancreatic cancer biomarkers

Targeting the cancer with one of the poorest survival rates in the world, the National Cancer Institute is funding a $2.3 million project to develop new molecular biomarkers for pancreatic cancer. Researchers from Van Andel Institute and Emory University will lead the 5-year project, along with researchers from other prominent institutions in the U.S. The study will focus on carbohydrate structures on the surface of cancer cells, known as glycans, using a technique called "shotgun glycomics." Press release | Article (reg. req.)

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.